Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DEVICE: KIBUR MICRODEVICE|DRUG: anthracycline and taxane based chemotherapy
Sponsor: Memorial Sloan Kettering Cancer Center